8 risultati
BACKGROUND OF THE INVENTION
This invention relates to the inhibition of activity of leukocyte derived cytokines, such as interleukin-1 and tumor necrosis factor, in humans and mammals. More specifically, this invention provides a method of inhibiting the activity of cytokines to arrest or alleviate
The subject of the present invention is new O-substituted derivatives of (+)-cyanidan-3-ol, especially 3-O-substituted derivatives of (+)-cyanidan-3-ol corresponding to the formula I ##STR2## in which R represents an optionally substituted hydrocarbon radical; an acyl radical of an organic
The subject of the present invention is new O-substituted derivatives of (+)-cyanidan-3-ol, especially 3-O-substituted derivatives of (+)-cyanidan-3-ol corresponding to the formula I ##STR2## in which R represents an optionally substituted hydrocarbon radical; an acyl radical of an organic
BACKGROUND OF THE INVENTION
This invention relates to the inhibition of activity of leukocyte derived cytokines, such as interleukin-1 and tumor necrosis factor, in humans and mammals. More specifically, this invention provides a method of inhibiting the activity of cytokines to arrest or alleviate
BACKGROUND OF THE INVENTION
The invention relates to the inhibition of activity of leukocyte derived cytokines, such as interleukin-1 and tumor necrosis factor, in humans and mammals. More specifically, this invention provides a method of inhibiting the activity of cytokines to arrest or alleviate
BACKGROUND OF THE INVENTION
This invention relates to the inhibition of activity of leukocyte derived cytokines, such as interleukin-1 and tumor necrosis factor, in humans and mammals. More specifically, this invention provides a method of inhibiting the activity of cytokines to arrest or alleviate
BACKGROUND OF THE INVENTION
This invention relates to the inhibition of activity of leukocyte derived cytokines, such as interleukin-1 and tumor necrosis factor, in humans and mammals. More specifically, this invention provides a method of inhibiting the activity of cytokines to arrest or alleviate
This application was filed under U.S.C. 371 of the application PCT/GB93/00708 filed Apr. 5, 1993.
This invention relates to therapeutically active hydroxamic acid derivatives, to processes for their preparation, to pharmaceutical compositions containing them, and to the use of such compounds in